Kidney disease often creeps in silently, and many patients aren’t diagnosed until major damage is already done. New research ...
Allschwil, Switzerland - February 06, 2026Idorsia Ltd (SIX: IDIA) announces the design of its FDA-agreed Phase 3 registration program for lucerastat in Fabry disease. Building on the robust biomarker ...
Research shows vitamin B12 deficiency is common in people with diabetes, highlighting the need for targeted screening and ...
New study reveals a central role of selenoprotein GPX3 in attenuating acute kidney injury Renal ischemia–reperfusion injury ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results